Carboxylic acid salts
eMolecules Ambeed / Nickel(II) stearate / 25g / 628567456 / A350401 / / 2223-95-2 / MFCD00054344 / 625.645 / C36H70NiO4
Ambeed / Nickel(II) stearate / 25g / 628567456 / A350401 / / 2223-95-2 / MFCD00054344 / 625.645 / C36H70NiO4
TARGETMOL CHEMICALS INC ISO-BMT-124110 FORMATE 5MG
Also available in 1 mg 10 mg 25 mg 50 mg 100 mg and bulk. Please contact Fisher for quotes. (Iso)-BMT-124110 Formate has an inhibitory effect on the protein serine/threonine kinase AAK and is used in the treatment of Parkinson's disease schizophrenia neuropathic pain and Alzheimer's disease.
AdipoGen R-3-Hydroxyisobutyric acid Na
Chemical. CAS 1228078-57-6. Formula C4H7O3 . Na. MW 103.1 . 23.0. Synthetic. Intermediate formed in the valine catabolism. It is a reactant of the enzymes involved in branched chain amino acid metabolism 3-hydroxyisobutyrate dehydrogenase and 3-hydroxyisobutyryl-CoA hydrolase and it was found to have increased concentrations in MS patient metabolic profiles. This compound may be used to study the distribution, characterization and kinetics of these enzymes. Shown to inhibit key enzymes of the energy metabolism.
AdipoGen D Galacturonic acid Na
Chemical. CAS 14984-39-5. Formula C6H9NaO7. MW 216.12. Synthetic. A sugar acid sodium salt preparation.
Sigma Organic Chemistry Sodium maleate dibasic | 250G | 371-47-1 | MFCD00013059 | >=98.0% (NT)
Sodium maleate dibasic | 250G | 371-47-1 | MFCD00013059 | >=98.0% (NT)
Sigma Aldrich Fine Chemicals Biosciences Sodium propionate, 137-40-6, MFCD00002759, 100 g
Linear Formula: CH3CH2COONa, Molecular Weight: 96.06, ≥99.0%, Synonym: Propionic acid sodium salt. Sodium propionate has been used as a supplement in transgalacto-oligosaccharides (TOS) medium for the isolation of bifidobacteria. It has been used as a supplement in SCFA (short-chain fatty acid) diet prepared for mice.
Sigma Organic Chemistry Sodium pyruvate | 25G | 113-24-6 | MFCD00002586
Sodium pyruvate, 25G
About This Item:
Storage: 2-8C
EINECS Number: 204-024-4
RIGAKU REAGENTS Potassium formate, 1M | 590-29-4 | MFCD00013100 | 250 mL
Potassium formate, 1M | Mol Wt: 84.115 | 590-29-4 | MFCD00013100 | 250 mL
Apexbio Technology LLC Rigosertib sodium salt 1225497-78-8 100mg
Rigosertib sodium salt (CAS 1225497-78-8) is a selective inhibitor targeting Polo-like kinase 1 (PLK1) with reported IC50 approximately 9 nM The compound notably decreases proliferation of cancer cell lines demonstrating nanomolar IC50 values in HeLa (115 nM) and C33A (45 nM) cells whereas normal cells (e g BJ and Ect1/E6E7) remain largely unaffected At concentrations exceeding 0 5 M rigosertib robustly induces G2/M phase arrest in cancer cells without significant cell cycle disruption at lower doses Additionally in vivo studies suggest its potential as a radiosensitizer in cervical carcinoma research
Apexbio Technology LLC Rigosertib sodium salt 1225497-78-8 25mg
Rigosertib sodium salt (CAS 1225497-78-8) is a selective inhibitor targeting Polo-like kinase 1 (PLK1) with reported IC50 approximately 9 nM The compound notably decreases proliferation of cancer cell lines demonstrating nanomolar IC50 values in HeLa (115 nM) and C33A (45 nM) cells whereas normal cells (e g BJ and Ect1/E6E7) remain largely unaffected At concentrations exceeding 0 5 M rigosertib robustly induces G2/M phase arrest in cancer cells without significant cell cycle disruption at lower doses Additionally in vivo studies suggest its potential as a radiosensitizer in cervical carcinoma research
Apexbio Technology LLC CEFOTAXIME SODIUM SALT 5G
Cefotaxime sodium (CAS 64485-93-4) is a third-generation cephalosporin antibiotic belonging to the -lactam group characterized by inhibition of bacterial cell-wall synthesis through binding to penicillin-binding proteins In vitro analyses show strong inhibitory efficacy against various bacterial species notably cefotaxime exhibits an MIC below 0 1 g/ml against Streptococcus pneumoniae It also demonstrates high activity against Haemophilus influenzae including -lactamase-producing strains In vivo mouse model studies revealed that combination therapy of cefotaxime with minocycline enhanced survival following Vibrio vulnificus infection compared to single-agent treatments Clinically cefotaxime has been evaluated in pneumonia therapy demonstrating good tolerance and therapeutic utility in targeting susceptible bacterial pathogens
Apexbio Technology LLC CEFOTAXIME SODIUM SALT 1G
Cefotaxime sodium (CAS 64485-93-4) is a third-generation cephalosporin antibiotic belonging to the -lactam group characterized by inhibition of bacterial cell-wall synthesis through binding to penicillin-binding proteins In vitro analyses show strong inhibitory efficacy against various bacterial species notably cefotaxime exhibits an MIC below 0 1 g/ml against Streptococcus pneumoniae It also demonstrates high activity against Haemophilus influenzae including -lactamase-producing strains In vivo mouse model studies revealed that combination therapy of cefotaxime with minocycline enhanced survival following Vibrio vulnificus infection compared to single-agent treatments Clinically cefotaxime has been evaluated in pneumonia therapy demonstrating good tolerance and therapeutic utility in targeting susceptible bacterial pathogens
Apexbio Technology LLC NADH SODIUM SALT 5G
NADH (sodium salt) (CAS 606-68-8) is the reduced form of nicotinamide adenine dinucleotide functioning as an essential coenzyme involved in cellular bioenergetics Biologically NADH participates as an electron carrier in metabolic pathways including glycolysis -oxidation and the tricarboxylic acid (TCA) cycle facilitating ATP generation through electron transport In biomedical research NADH (sodium salt) is frequently applied to investigate cellular energy metabolism and elucidate mechanisms underpinning metabolic disorders
Apexbio Technology LLC SIMVASTATIN SODIUM SALT 10MG
Simvastatin (sodium salt) (CAS 101314-97-0) is an inhibitor of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase a critical enzyme controlling the rate-limiting step in cholesterol biosynthesis It binds with high affinity to HMG-CoA reductase exhibiting a Ki of approximately 0 12 nM In hepatocyte-derived Hep G2 cells simvastatin demonstrated potent suppression of cholesterol biosynthesis reducing the incorporation of radiolabeled acetate into sterols (IC50 15 nM) Animal studies with orally administered simvastatin indicated marked reduction in plasma cholesterol levels validating its utility in experimental models exploring cholesterol regulation and lipid metabolism